Researchers from Imperial College London have found evidence that suggests that psilocybin, the psychoactive compound of magic mushrooms, might be useful in treating #depression.
Patients in the study were given two doses of psilocybin. The first dose of 10 mg was given immediately and the second dose of 25 mg was given a week after the first. The patients reported how they felt by completing clinical questionnaires.
Each patient showed less depressive symptoms at the one week post-treatment mark. . “We have shown for the first time clear changes in brain activity in depressed people treated with psilocybin after failing to respond to conventional treatments,” lead author Dr Robin Carhart-Harris, head of psychedelic research at Imperial, said in a statement.
A study of eleven types of mushrooms - some already used for medicinal purposes - found they increased the brain's grey matter by raising the production of a chemical called nerve growth factor (NGH). The findings, published in the Journal of Medicinal Food, suggest mushrooms are a potential 'superfood' which could reduce or delay development of #dementia.
Researchers reviewed the scientific evidence with regard to their anti-Alzheimer's effects and found "they may fulfil a preventive function against the development of #Alzheimer's disease”. Professor Vikineswary Sabaratnam, of Malaya University in Kuala Lumpur, said: "Regular consumption of the #mushrooms may reduce or delay development of age-related neuro-degeneration. #uglybynature